eXp World (EXPI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
24 Feb, 2026Executive summary
Revenue grew 4% year-over-year to $4.8 billion in 2025, with Q4 revenue up 9% to $1.2 billion.
International revenue surged 67% to $147 million, driven by expansion into 7 new countries.
Ended 2025 with 83,060 agents worldwide, with improved retention, productivity, and a 17% reduction in attrition.
Significant investments in AI, technology, and platform expansion supported operational improvements and agent engagement.
Distributed $87.0 million to shareholders in 2025 through stock repurchases and dividends.
Financial highlights
Gross profit for 2025 was $333.6 million; operating loss was $21.5 million for the year, $12.7 million for Q4.
Adjusted EBITDA was $33.2 million for 2025 and $2.1 million for Q4, both positive but down year-over-year.
Cash and cash equivalents rose to $124.2 million at year-end 2025.
Net cash provided by operating activities was $118.6 million for 2025.
Full-year operating expenses decreased to $355.0 million from $361.4 million in 2024.
Outlook and guidance
Q1 2026 revenue expected between $960 million-$980 million; Adjusted EBITDA $2 million-$5 million.
Full-year 2026 revenue guidance is $4.85 billion-$5.15 billion; Adjusted EBITDA $50 million-$75 million.
Operating expenses for 2026 projected at $325–$345 million.
Continued focus on leveraging technology investments for margin expansion and operational efficiency.
Latest events from eXp World
- Shareholders are asked to approve redomestication to Texas, aligning governance with business needs.EXPI
Proxy filing24 Apr 2026 - Shareholders will vote on redomestication to Texas, with key risks and benefits highlighted.EXPI
Proxy filing23 Apr 2026 - Shareholders will vote on redomestication to Texas, with new litigation thresholds and outlined risks.EXPI
Proxy filing23 Apr 2026 - Shareholders are voting on a Texas redomestication, with enhanced governance and voting safeguards.EXPI
Proxy filing23 Apr 2026 - Stockholders will vote on redomestication to Texas, aiming for financial and governance benefits.EXPI
Proxy filing22 Apr 2026 - Proxy solicitor engaged for 2026 Annual Meeting to support redomestication vote.EXPI
Proxy filing20 Apr 2026 - Shareholders to vote on Texas redomestication, governance, and compensation changes.EXPI
Proxy Filing9 Mar 2026 - Board recommends approval of director elections, auditor, executive pay, and Texas redomestication.EXPI
Proxy Filing25 Feb 2026 - Q2 2024 revenue up 5% to $1.3B, adjusted EBITDA up 22%, and $56M returned to shareholders.EXPI
Q2 20242 Feb 2026